Levosimendan for Hemodynamic Support after Cardiac Surgery

New England Journal of Medicine

Volumn 376, Issue 21, 2017, Pages 2021-2031

  Landoni, Giovanni ^a,b   Lomivorotov, Vladimir V ^j   Alvaro, Gabriele ^c   Lobreglio, Rosetta ^d   Pisano, Antonio ^g   Guarracino, Fabio ^h   Calabrò, Maria G ^a   Grigoryev, Evgeny V ^k   Likhvantsev, Valery V ^l   Salgado Filho, Marcello F ⁿ   Bianchi, Alessandro ^e   Pasyuga, Vadim V ^m   Baiocchi, Massimo ⁱ   Pappalardo, Federico ^a   Monaco, Fabrizio ^a   Boboshko, Vladimir A ^j   Abubakirov, Marat N ^j   Amantea, Bruno ^c   Lembo, Rosalba ^a   Brazzi, Luca ^d,f   Verniero, Luigi ^g   Bertini, Pietro ^h   Scandroglio, Anna M ^a   Bove, Tiziana ^a   Belletti, Alessandro ^a   Michienzi, Maria G ^c   Shukevich, Dmitriy L ^k   Zabelina, Tatiana S ^l   Bellomo, Rinaldo ^o   Zangrillo, Alberto ^a,b   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Universitaria Mater Domini Germaneto   (Italy)

^d CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^e MAURIZIANO HOSPITAL   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g MONALDI HOSPITAL   (Italy)

^h UNIVERSITY HOSPITAL OF PISA   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^k RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^l M F VLADIMIRSKY MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE   (Russian Federation)

^m Federal Center for Cardiovascular Surgery   (Russian Federation)

ⁿ FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^o UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEVOSIMENDAN; PLACEBO; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ATTRIBUTABLE RISK; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART SURGERY; HEMODYNAMIC SUPPORT; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; CARDIAC OUTPUT, LOW; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HEART STROKE VOLUME; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT FAILURE;

AGED; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; RESPIRATION, ARTIFICIAL; STROKE VOLUME; TREATMENT FAILURE;

EID: 85019861977     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1616325     Document Type: Article

References (30)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics - 2016 update: a report from the American Heart Association. Circulation 2016; 133(4): e38-e360.
2. Mebazaa A, Pitsis AA, Rudiger A, et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14: 201.
3. Lomivorotov VV, Efremov SM, Kirov MY, Fominskiy EV, Karaskov AM. Low-cardiac- output syndrome after cardiac surgery. J Cardiothorac Vasc Anesth 2017;31:291-308.
4. Maganti M, Badiwala M, Sheikh A, et al. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg 2010; 140: 790-6.
5. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery - a systematic literature review. Crit Care 2005; 9: 266-79.
6. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur J Heart Fail 2002; 4: 515-29.
7. Shahin J, DeVarennes B, Tse CW, Amarica DA, Dial S. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 2011; 15: R162.
8. Pollesello P, Parissis J, Kivikko M, Harjola VP. Levosimendan meta-analyses: is there a pattern in the effect on mortality? Int J Cardiol 2016; 209: 77-83.
9. Landoni G, Mizzi A, Biondi-Zoccai G, et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010; 24: 51-7.
10. Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization: a meta-analysis of randomized controlled studies. Crit Care Med 2012; 40: 634-46.
11. Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2013; 27: 1224-32.
12. Greco T, Calabró MG, Covello RD, et al. A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 2015; 114: 746-56.
13. Papp Z, Édes I, Fruhwald S, et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol 2012; 159: 82-7.
14. Nieminen MS, Fruhwald S, Heunks LM, et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel 2013; 5: 227-45.
15. Zangrillo A, Alvaro G, Pisano A, et al. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): rationale and design. Am Heart J 2016; 177: 66-73.
16. Ford I, Norrie J. Pragmatic trials. N Engl J Med 2016; 375: 454-63.
17. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
18. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996; 335: 1857-63.
19. Ridgeon E, Bellomo R, Myburgh J, et al. Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability. Crit Care Resusc 2016; 18: 50-4.
20. DeMets DL, Pocock SJ, Julian DG. The agonising negative trend in monitoring of clinical trials. Lancet 1999; 354: 1983-8.
21. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17: 873-90.
22. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117: 686-97.
23. Mehta RH, Leimberger JD, van Diepen S, et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. DOI: 10.1056/NEJMoa1616218.
24. Zangrillo A, Putzu A, Monaco F, et al. Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials. J Crit Care 2015; 30: 908-13.
25. Gordon AC, Perkins GD, Singer M, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; 375: 1638-48.
26. Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 2007; 297: 1883-91.
27. Packer M, Colucci W, Fisher L, et al. Effect of levosimendan on the shortterm clinical course of patients with acutely decompensated heart failure. JACC Heart Fail 2013; 1: 103-11.
28. Rudiger A, Businger F, Streit M, Schmid ER, Maggiorini M, Follath F. Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure. Swiss Med Wkly 2009; 139: 110-6.
29. St André AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery. Crit Care Med 2005; 33: 2082-93.
30. Toller W, Heringlake M, Guarracino F, et al. Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol 2015; 184: 323-36.